Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats
SUMMARY We have modelled elaidyl-sulfamide (ES), a sulfamoyl analogue of oleoylethanolamide (OEA). ES is a lipid mediator of satiety that works through the peroxisome proliferator-activated receptor alpha (PPARα). We have characterised the pharmacological profile of ES (0.3-3 mg/kg body weight) by m...
Saved in:
Main Authors: | Juan Manuel Decara (Author), Miguel Romero-Cuevas (Author), Patricia Rivera (Author), Manuel Macias-González (Author), Margarita Vida (Author), Francisco J. Pavón (Author), Antonia Serrano (Author), Carolina Cano (Author), Nieves Fresno (Author), Ruth Pérez-Fernández (Author), Fernando Rodríguez de Fonseca (Author), Juan Suárez (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2012-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization
by: Ying Li, et al.
Published: (2023) -
Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat
by: Juan Suárez, et al.
Published: (2014) -
Octadecylpropyl Sulfamide Reduces Neurodegeneration and Restores the Memory Deficits Induced by Hypoxia-Ischemia in Mice
by: Elk Kossatz, et al.
Published: (2018) -
Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases
by: Ashok Aspatwar, et al.
Published: (2020) -
PPARγ Agonists: Emergent Therapy in Endometriosis
by: Alexandre Vallée, et al.
Published: (2021)